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The spacer protein Spc110p targets calmodulin to the central plaque of the
yeast spindle pole body 
Anne Spang, Katrin Grein and Elmar Schiebel*
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*Author for correspondenceYeast calmodulin (CaM) was found to be localized to the
microtubule organizing centre, the spindle pole body. The
spindle pole body is a multi-layered structure consisting of
outer, central and inner plaques. In this paper, we report
that a fraction of CaM is in association with the central
plaque of the spindle pole body. This localization is
dependent on the calmodulin-binding site of another
spindle pole body component, Spc110p, which serves as a
spacer connecting the inner plaque with the central plaque.
Since the CaM-binding site of Spc110p is located near the
carboxy terminus, Spc110p-dependent localization of
calmodulin defines the orientation of Spc110p with the
carboxy terminus towards the central plaque and the
amino terminus towards the inner plaque. This orientation
of Spc110p was confirmed using antibodies specific for the
amino-terminal end of Spc110p, which predominantly
labelled the inner plaque. In addition, synthetic peptides
corresponding to the calmodulin-binding site of Spc110p
bound to calmodulin with a Kd in the nanomolar range and
nearly independent of Ca2+. 
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SUMMARYINTRODUCTION
In the yeast Saccharomyces cerevisiae, microtubule organiz-
ing functions are provided by the spindle pole body (SPB), a
multilaminated organelle associated with the nuclear envelope
throughout the life cycle of this organism (Byers and Goetsch,
1975). A number of SPB substructures can be discriminated by
electron microscopy (Byers and Goetsch, 1975; Fig. 6). The
inner and outer plaques of the SPB organize the cytoplasmic
and nuclear microtubules, respectively. The central plaque is
embedded in the nuclear envelope and is connected by fibres
to the inner plaque of the SPB (Kilmartin et al., 1993; Rout
and Kilmartin, 1990). The central plaque itself is divided by
the central line into nuclear- and cytoplasmic-directed sections
(Spang et al., 1993). Further, an intermediate line was observed
in between the outer and central plaques of the SPB (Rout and
Kilmartin, 1990). An additional SPB substructure is the half
bridge, which appears as a darkly stained strip along the
nuclear envelope on one side of the SPB (Byers and Goetsch,
1975). The half bridge has an important function in SPB dupli-
cation (Byers, 1981).
The fibres connecting the central with the inner plaque
contain the essential Spc110p protein (Kilmartin et al., 1993).
Spc110p was first described as a component of the yeast
nucleoskeleton (Mirzayan et al., 1992). Further studies identi-
fied Spc110p as a component of the SPB (Kilmartin et al.,
1993). Spc110p has a long central region with a predicted
coiled-coil structure. Truncations in the coiled-coil domain ofSpc110p change the spacing between the central and inner
plaques of the SPB (Kilmartin et al., 1993). Recently, a
calmodulin (CaM) binding site was identified within the
carboxy-terminal domain of Spc110p. Mutations in the CaM-
binding site of Spc110p, which abolish CaM binding in vitro,
are lethal for cells. However, the total deletion of the CaM-
binding domain of Spc110p does not affect viability (Geiser et
al., 1993; Stirling et al., 1994). This result may be explained
by an auto-inhibitory function of the CaM binding site,
analogous to myosin light chain kinase (Yano et al., 1993) or
Ca2+/CaM-dependent protein kinase (Schulman et al., 1992).
Some mutants in the structural gene of CaM (CMD1) like
cmd1-1 and cmd1-101 show mitotic defects (Davis, 1992; Ohya
and Botstein, 1994). In the case of cmd1-1, this defect is sup-
pressed by deleting the CaM-binding site near the carboxy
terminus of Spc110p (Geiser et al., 1993). This suggests that
Spc110p is one of the essential targets of CaM in yeast. Remark-
ably, CaM fulfils its essential functions without Ca2+-binding
(Geiser et al., 1991). Based on this finding it has been suggested
that the interaction of CaM with essential targets is Ca2+-inde-
pendent. Therefore the Ca2+-dependent binding of CaM to
Spc110p in an in vitro assay was surprising (Spang et al., 1995).
Furthermore, while the interaction of CaM with the SPB has
been demonstrated (Geiser et al., 1993; Stirling et al., 1994), it
is unknown whether this localization is dependent on Spc110p,
which is expected when CaM binds to the SPB via Spc110p. In
this case, a deletion of the CaM-binding site of Spc110p should
severely affect the localization of CaM to the SPB.
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plaque of the SPB. This association is dependent on the CaM-
binding site of Spc110p. The Spc110p-dependent localization
of CaM with the central plaque defines the orientation of
Spc110p in the SPB with the CaM-binding site at the carboxy-
terminal end of Spc110p near the central plaque. In agreement
with this conclusion, an antibody specific for the amino
terminus of Spc110p predominantly labelled the inner plaque
of the SPB, confirming that Spc110p is an elongated protein
connecting the central with inner plaques. In addition, by an
in vitro assay we could demonstrate that CaM binds to the
CaM-binding site of Spc110p with a Kd in the nanomolar
range. 
MATERIALS AND METHODS
Media, bacterial transformation, DNA techniques
Media for growth of yeast were as described by Guthrie and Fink
(1991). DNA manipulations were performed as described by
Sambrook et al. (1989).
Cloning of SPC110, SPC110 disruption cassette, GST-
SPC110 gene fusion
SPC110 was cloned by PCR using primers NUF1-11 (5¢ -
CGTGGGATCCGGAGCTCCTTGTAGACA-3¢ ) and NUF1-14 (5¢ -
CGTGGGATCCGAAGTTCAAAGAACTCC-3¢ ; Mirzayan et al.,
1992). Chromosomal DNA from strain YPH499 (Sikorski and Hieter,
1989) was used as a template. Primers NUF1-11 and NUF1-14 each
carry a BamHI restriction site. The 3.48 kb PCR fragment was cloned
into plasmid pBluescript SK (Stratagene; pSM104). The 3.48 BamHI
fragment of pSM104 was cloned into the URA3- or TRP1-based
vectors pRS316 or pRS314 (Sikorski and Hieter, 1989) to give
plasmids pCM94 and pCM132, respectively. spc110-407 of plasmid
pJG94 (Geiser et al., 1993) on a 3.3 kb PvuII-SalI fragment was
inserted into the SmaI-SalI restriction sites of pRS314 (pSM237).
For the construction of the SPC110 disruption cassette of pSM249,
plasmid pSM104 was restricted with NsiI and SnaBI, which removes
76% of the coding region of SPC110 including the region that encodes
the CaM-binding site. The HIS3 gene on a PstI-SmaI fragment was
cloned into the NsiI-SnaBI restriction sites of pSM104.
The construction of GST-N-SPC110 (pSM72) and GST-C-SPC110
(pSM74) in vector pGEX-3X (Pharmacia) has been described (Spang
et al., 1995). Plasmid pSM236 carrying GST-C-spc110-407 on pGEX-
3X was constructed identically.
Constructions of yeast strains
Yeast strain YPH500 (Sikorski and Hieter, 1989) was transformed
with plasmid pCM94 carrying SPC110 on plasmid pRS316
(ESM195). The chromosomal SPC110 of ESM195 was disrupted by
the one step gene replacement method of Rothstein (1983) using the
SPC110 disruption cassette of pSM249 (D spc110::HIS3). 
Strain ESM211 was transformed with plasmids pSM237 (ESM214-
1) or pCM132 (ESM213-1). Strains ESM214-1 and ESM213-1 were
incubated on 5-fluoroorotic acid (5-FOA) plates to select for colonies
which spontaneously lost pCM94. SPC110 function is now provided
by either SPC110 (ESM213-2) or SPC110-407 (ESM214-2) on
plasmid pRS314.
Affinity-purified CaM antibodies
CMD1 was amplifed by PCR as described by Spang et al. (1995)
and cloned into pRS315 (pCM137). CMD1 of pCM137 was
amplified by PCR using primers CaM-BamHI (5 ¢ -CGTGGGATC-
CTCCAATCTTACCGA-3 ¢ ) and T7 (5 ¢ -AATACGACTCAC-
CATAG-3 ¢ ). Primer CaM-BamHI introduces a BamHI restrictionsite upstream of the translation initiation codon of CMD1. The PCR
product was restricted with BamHI and SnaBI and cloned into vector
pGEX-4T-3 (Pharmacia, pSM178). Recombinant GST-CaM fusion
protein was isolated from E. coli BL21 (DE3) (Tabor and Richard-
son, 1985) carrying pSM178, as described by Spang et al. (1993).
GST-CaM was injected into rabbits as described by Harlow and
Lane (1988). Affinity purified anti-CaM antibodies were obtained
as described by Spang et al. (1993) using purified, recombinant
CaM. 
Nuclei isolation, SPB preparation, cell extracts
Nuclei and SPBs from strains YPH499 and ESM214-2 were isolated
as described by Rout and Kilmartin (1990). Protein extracts were
prepared according to Ausubel et al. (1994).
Immunoelectron microscopy, immunofluorescence of
yeast cells
Immunoelectron microscopy of whole yeast cells and isolated SPBs
was performed with affinity-purified rabbit anti-N-Spc110p (Spang et
al., 1995), anti-CaM or mouse monoclonal anti-b -tubulin antibodies
(WA3), according to Preuss et al. (1991). Gold particles bound to
protein A or rabbit anti-mouse IgGs (BioCell) were visualized in a
Jeol JEM 100B electron microscope. No signal was obtained when
cells were incubated either with secondary antibodies only or with
preimmune serum. 
Immunofluorescence of yeast cells was performed as described by
Adams and Pringle (1989) or Rout and Kilmartin (1990). Affinity-
purified anti-N-Spc110p and anti-CaM antibodies were used.
Secondary antibodies were goat anti-rabbit IgG and rabbit anti-goat
IgG, both conjugated with Cy3 (Jackson ImmunoResearch Labora-
tories). No signal was obtained when cells were incubated either with
secondary antibodies only or with preimmune serum. 
Immunoblotting, protein determination
Protein concentration of samples was determined by the method of
Bradford (1976). Proteins were separated by SDS-PAGE (Laemmli,
1970). Immunoblotting was performed as described by Spang et al.
(1993). Detection was made by enhanced chemilumenscence. The
primary antibodies were rabbit anti-CaM and goat anti-N-Spc110p
(Spang et al., 1995). Secondary antibodies were goat anti-rabbit IgG
(Bio-Rad), rabbit anti-goat IgG and donkey anti-goat (Jackson
ImmunoResearch Laboratories) conjugated with horseradish peroxi-
dase.
Purification of CaM, binding of CaM to synthetic peptides,
overlay assay
Yeast CaM was expressed from the phage T7 promoter in E. coli
BL21 (DE3, pSM71) (Studier and Moffat, 1986; Tabor and Richard-
son, 1985) as described by Spang et al. (1995), and purified according
to H. Wiech et al. (unpublished). Briefly, after a temperature precip-
itation step (10 minutes, 80°C) the supernatant was applied onto a
DEAE-Cellulose column (Sigma). CaM-containing fractions were
further enriched by a Phenyl Sepharose step (high performance;
Pharmacia) and finally purified using a Superdex 75 HiLoad 16/60
column on a FPLC system (Pharmacia). 
The synthetic peptides RRWSFKTVALLVLACVMKRI and
RRLSFKTVAWLVLASVRMKRI were synthesized by the Max-
Planck Peptide Service. The molecular mass of the C8 reverse-phase
HPLC-purified peptides was confirmed by mass spectrometry. The
binding of the synthetic peptides to purified yeast CaM was deter-
mined by tryptophan fluorescence in Ca2+-buffers (Molecular Probes,
Eugene, OR) containing 10 mM MOPS, pH 7.2, 100 mM KCl and 1
mM DTT. The excitation wavelength was 295 nm. The emission was
measured at 330 nm. The Kd values were calculated using the program
Psi-Plot. [35S]CaM was labeled and purified as described by Spang et
al. (1995). The overlay assay was performed in the presence of 1 mM
Ca2+ (Spang et al., 1995).
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CaM is a component of the central plaque of the
SPB
CaM was localized to the SPB by indirect immunofluorescence
using special fixation conditions (Geiser et al., 1993; Stirling
et al., 1994) that preserve SPB antigens (Rout and Kilmartin,
1990). To understand the function of CaM at the SPB, it is
important to determine its association with substructures of the
SPB. Functions for some SPB substructures were deduced
from ultrastructural analysis (Byers, 1981). Most interestingly,
the inner and central plaques are connected by fibres that
contain Spc110p, which carries a CaM-binding site at its
carboxy-terminal end (Geiser et al., 1993; Kilmartin et al.,
1993). 
For these localization studies, we prepared affinity-purified
anti-CaM antibodies. The specificity of the affinity-purified
anti-CaM antibodies was tested by immunoblotting using a
total yeast extract. The anti-CaM antibodies recognized only
one protein of about 16 kDa, the predicted molecular mass of
CaM (Fig. 1A, lane 1). This protein revealed the same
migration behaviour as recombinant CaM (lane 4). Cdc31p,Fig. 1. CaM is a component of the central
plaque of the SPB. (A). The anti-CaM
antibodies are specific. Total yeast extract (80
m g; lane 1), E. coli extracts (80 m g each)
expressing no recombinant protein (lane 2),
Cdc31p (lane 3) or CaM (lane 4), were
separated by SDS-PAGE, transferred onto a
nitrocellulose membrane and incubated with
affinity-purified anti-CaM antibodies. The
molecular masses of marker proteins are
indicated in kDa. (B-F) Immunoelectron
microscopy of isolated SPBs. Ultrathin sections
of isolated SPB were incubated with affinity-
purified rabbit anti-CaM antibodies followed by
Protein A-gold. The gold particles have a
diameter of 10 nm. The small arrowheads in
(B,D and E) indicate the position of gold
particles associated with microtubules. Large
arrowheads: c, central plaque; cl, central line; i,
inner plaque; il, intermediate line; m,
microtubules; o, outer plaque. Bars: (B,C,D) 50
nm; (E,F) 125 nm.another Ca2+-binding protein, which is 38% identical to CaM,
was not detected by the antibodies (lane 3), confirming that our
affinity-purified anti-CaM antibodies are specific for CaM.
Using the anti-CaM antibodies, we observed the same cellular
distribution of CaM in yeast cells as has been reported before
(data not shown; Brockerhoff and Davis, 1992). CaM was
mainly localized at the sites of bud growth, but also faintly dis-
tributed throughout the cell. In addition, SPB staining was
observed using the fixation conditions described by Rout and
Kilmartin (1990) (Fig. 2C).
Next, the localization of CaM was investigated by immuno-
electron microscopy using isolated SPBs (Rout and Kilmartin,
1990). Enriched fractions of SPBs contain about 500-fold more
SPBs per volume than yeast cells, making it much easier to
obtain a representative view of the localization of a SPB
component. More than 1,000 SPBs were investigated, of which
about 45% were stained with gold particles. The labelling of
only 45% of the SPBs is explained by the post-embedding
labelling technique, where only epitopes exposed on the surface
of the section are accessible for detection by the antibody. The
outer and central plaques were clearly detectable in the isolated
SPBs. The central plaque was disrupted by the central line
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Fig. 2. The localization of CaM to the central plaque is
dependent on the CaM-binding site of Spc110p.
(A) CaM does not interact with Spc110-407p. GST-C-
Spc110-407p (lanes 1 and 4), GST-C-Spc110p (lanes 2
and 5) and GST-N-Spc110p (lanes 3 and 6) were
expressed in E. coli and separated by SDS-PAGE. The
expression of the recombinant proteins was tested by
Coomassie Blue staining (lanes 1 to 3). The recombinant
proteins are indicated by the asterisk. Lanes 4 to 6 were
transferred onto a nitrocellulose membrane. The
membrane was incubated with [35S]CaM and
subsequently subjected to autoradiography. The
molecular masses of marker proteins are indicated in
kDa. (B) spc110-407 is expressed in yeast. An
immunoblot of yeast extracts (80 m g) from wild-type
cells (lane 1) and cells expressing spc110-407 (ESM214-
2; lane 2) were incubated with affinity-purified goat anti-
N-Spc110p antibodies. (C) CaM is not associated with
SPBs of spc110-407 cells. SPC110 and spc110-407 cells
were fixed with acetone and methanol (Rout and
Kilmartin, 1990) and incubated with mouse monoclonal
anti-90-kDa and rabbit anti-CaM antibodies. Secondary
antibodies were goat anti-mouse IgGs coupled to Cy3 or
goat anti-rabbit IgGs coupled to FITC. Cells were
analyzed by a Zeiss Axiovert 134 confocal microscope.
The green signal indicates the localization of CaM. The
red signal corresponds to the localization of the 90 kDa
SPB protein. The yellow signal in SPC110 cells results
from the colocalization of CaM and the 90 kDa SPB
protein. (D) CaM is not associated with SPBs from
spc110-407 cells. Immunoelectron microscopy of
isolated SPBs from spc110-407 cells. A double-labelling
experiment was performed with affinity-purified rabbit
anti-CaM (15 nm gold) and mouse monoclonal anti-b -
tubulin antibodies (5 nm gold). The arrowheads point to
the 5 nm gold particles. Note, no 15 nm gold particles
(CaM) associated with SPBs from spc110-407 cells were
observed, indicating that the localization of CaM was
dependent on the CaM-binding site of Spc110p. c,
central plaque; i, inner plaque; o, outer plaque. Bars: (C)
5 m m; (D) 50 nm.
SPC110 cells spc110-407 cells(Spang et al., 1993; Fig. 1B,D,F). The inner plaque is less
electron dense compared to the others and therefore difficult to
see in electron micrographs. Nuclear microtubules were asso-
ciated with the inner plaque of the isolated SPBs. In contrast,
the cytoplasmic microtubules were lost during SPB purification
(Rout and Kilmartin, 1990). The CaM signal (3 to 5 gold
particles) was associated with the central plaque of the SPB
(Fig. 1B-E). Only 1% of the gold particles were found at other
SPB substructures. Interestingly the half bridge, the substruc-
ture to which the related Cdc31p has been localized (Spang et
al., 1993), was not stained by the anti-CaM antibodies. This
clearly demonstrates that CaM and Cdc31p are associated with
different substructures of the SPB and most likely bind to
different target proteins. Occasionally, the CaM signal was
found to be associated with microtubules (small arrowheads in
Fig. 1B,D,E), which is consistent with the notion that CaM
binds to cytoskeletal components (Cohen and Klee, 1988). Interaction of CaM with Spc110p is required for its
localization to the SPB
Spc110p possesses a CaM-binding site at its carboxy-terminal
domain (Geiser et al., 1993; Stirling et al., 1994). However,
whether CaM binds to the SPB via Spc110p or an additional
SPB component has not been investigated. To test this, we used
spc110-407, which contains a frame-shift mutation that
converts codon 864 to a stop codon, thereby deleting the CaM-
binding site of Spc110p (amino acids 900 to 916; Geiser et al.,
1993; Stirling et al., 1994). We first confirmed that CaM does
not interact with Spc110-407p. Therefore, GST-C-Spc110-
407p (Fig. 2A, lane 1; fusion protein is marked by an asterisk),
GST-C-Spc110p (lane 2) and GST-N-Spc110p (lane 3) were
produced in E. coli. While CaM bound to the carboxy-terminal
domain of Spc110p (GST-C-Spc110p; lane 5), no interaction
was observed with GST-C-Spc110-407p (lane 4) or the amino-
terminal portion of Spc110p fused to GST (GST-N-Spc110p;
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Fig. 3. Spc110p signal is also present in the nucleus.
(A) Immunofluorescence of yeast cells with affinity-purified rabbit
anti-N-Spc110p antibodies. DNA was stained with DAPI.
(B) Immunoelectron microscopy of yeast cells with affinity-purified
rabbit anti-N-Spc110p antibodies. The labelling was visualized with
Protein A-gold (10 nm). The small arrowheads point to the gold
particles distributed throughout the nucleus. The large arrowhead
indicates the position of the central plaque of the SPB. Inset in B is a
threefold enlargement of the SPB with Spc110p signal on the nuclear
side of the central plaque. c, central plaque; C, cytoplasm; N,
nucleus. (C) The distribution of the Spc110p signal in sections of
100 cells was determined. ‘Membranes’ indicates the gold particles
associated with membranous structures of uncertain origin and ‘Cell
Membranes’ the gold particles associated with the cytoplasmic
membrane. Bars: (A) 5 m m; (B) 0.36 m m.lane 6). We then constructed strain ESM214-2 carrying the
spc110-407 allele. This was possible, since the deletion of the
CaM-binding site of Spc110p does not affect viability (Stirling
et al., 1994). We confirmed the truncation of Spc110p inspc110-407 cells. In agreement with a deletion of the 86
carboxy-terminal amino acids of Spc110p, the electrophoretic
mobility of Spc110-407p (Fig. 2B; lane 2) was increased in
comparison to Spc110p (lane 1). 
SPC110 and spc110-407 cells were fixed with acetone and
methanol and incubated with antibodies against the 90 kDa
SPB component (red colour in Fig. 2C) and CaM (green
colour). In these experiments cytoplasmic CaM was not
clearly localized with the sites of bud growth (Brockerhoff
and Davis, 1992), explained by the acetone-methanol fixation,
which does not preserve all substructures of a yeast cell. A
fraction of CaM was associated with the SPB in SPC110 cells,
indicated by the yellow colour resulting from an overlap of
the red anti-90-kDa and green anti-CaM signals. In contrast,
the SPB of spc110-407 cells was only stained by the anti-90-
kDa antibodies (red), suggesting that CaM was not associated
with these SPBs. 
The same result was obtained using enriched SPBs from
spc110-407 cells. While in all inspected SPBs (n=1,000) the
attached microtubules were labelled by the anti-tubulin
antibody (5 nm gold particles; arrowheads), no CaM signal (15
nm gold) was detected at the SPB (Fig. 2D). Taken together,
our results suggest that CaM binds to the SPB via the carboxy-
terminal CaM-binding site of Spc110p. 
The amino-terminal domain of Spc110p is close to
the inner plaque of the SPB
The Spc110p-dependent association of CaM with the central
plaque suggests that the CaM-binding site, and thereby the
carboxy-terminal domain of Spc110p, is in close proximity
with the central plaque of the SPB. Since it has been suggested
that Spc110p is a filamentous protein connecting the central
plaque with the inner plaque (Kilmartin et al., 1993), the
amino-terminal domain of Spc110p may associate with the
inner plaque. We tested this hypothesis by immunoelectron
microscopy using affinity-purified anti-Spc110p antibodies,
which were directed against the amino-terminal 175 amino
acids of Spc110p (Spang et al., 1993).
As reported before (Rout and Kilmartin, 1990), our anti-N-
Spc110p antibody detected Spc110p at the SPB of yeast cells
by indirect immunofluorescence (Fig. 3A). Additionally,
Spc110p signal was observed throughout the nucleus (Fig. 3A,
compare anti-N-Spc110p with DAPI). Interestingly, depending
on the manner of fixation of yeast cells, Spc110p has been
described as component of the SPB (Rout and Kilmartin,
1990), the nucleoskeleton (Mirzayan et al., 1992), or the SPB
and the nucleus (Kilmartin et al., 1993). 
The dual localization of Spc110p was confirmed by immu-
noelectron microscopy of cells using the anti-N-Spc110p anti-
bodies. The SPB appeared by the fixation and embedding
technique of Preuss et al. (1991) as a discontinuity of the
nuclear envelope by the central plaque (Fig. 3B; large
arrowhead points to the central plaque; Spang et al., 1993). The
central line interrupting the central plaque was clearly
detectable. Outer and inner plaques as well as microtubules
were not resolved by this technique (Spang et al., 1993). SPBs
were labelled by the anti-N-Spc110p antibodies. Up to six gold
particles were located on the nuclear side of the central plaque.
Besides SPB staining, gold particles were distributed over the
entire cell (Fig. 3B). We quantified the localization of
Spc110p-signal in 100 sections of cells (Fig. 3C), not counting
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Fig. 4. The amino terminus of Spc110p is
directed towards the inner plaque of the SPB.
(A-D) Immunoelectron microscopy of
isolated SPB. Ultrathin sections of isolated
SPBs were incubated with affinity-purified
rabbit anti-N-Spc110p antibodies followed by
Protein A-gold (10 nm). (E-F) Spc110-407p
is associated with the SPB. Immunoelectron
microscopy of SPBs from spc110-407 cells
using anti-N-Spc110p antibodies. c, central
plaque; i, inner plaque; il, intermediate line;
m, microtubules; o, outer plaque. Bars:
(A-D) 50 nm; (E) 50 nm. the SPB signals. About 75% of the Spc110p signal was found
in the nucleus. The remaining signal was associated with either
the vacuole (3%), the cytoplasmic membrane (2%; ‘Cell
Membranes’; Fig. 3C) or membranous structures of uncertain
origin (20%; ‘Membranes’).
Next, ultrathin sections of enriched SPB were subjected to
immunoelectron microscopy with anti-N-Spc110p antibodies.
About 1,000 SPBs were inspected, of which 40% were asso-
ciated with gold particles. In about 85% of the SPBs with a
Spc110p signal, 2-10 gold particles were found close to or
directly at the inner plaque (Fig. 4A to D). In most of the other
cases (10%), the signal was located between the central and
inner plaques but never at the central plaque. The remaining
gold particles (5%) were associated with other SPB substruc-
tures. No signal was observed when the first antibody was
omitted, showing that the labelling was dependent on the anti-
N-Spc110p antibody. 
We tested whether the deletion of the CaM-binding site of
Spc110p affects the localization of this protein at the SPB.
SPBs from spc110-407 cells were stained with the anti-N-
Spc110p antibody. The localization of gold particles with sub-structures of Spc110-407p SPBs (Fig. 4E and F) was as
described for wild-type SPBs (Fig. 4A-D), indicating that CaM
is not required for the proper localization of Spc110p at the
SPB. In summary, we conclude that the amino terminus of
Spc110p is associated with the inner plaque of the SPB.
CaM-binding to synthetic Spc110p peptides
To further characterize the interaction of CaM with Spc110p,
we studied the binding of purified CaM to synthetic peptides
corresponding to the CaM-binding site of Spc110p by a tryp-
tophan fluorescence assay. The fluorescent amino acid trypto-
phan was introduced for leucine in positions 3 (peptide 1) or
10 (peptide 2) of the synthetic Spc110p-peptides (Fig. 5A). To
avoid artefacts of disulphide bond formation by the cysteine in
position 15, this amino acid was replaced in peptide 2 by a
serine residue. Peptides 1 and 2 showed a strong fluorescent
signal with a maximum at 350 nm (Fig. 5B) when excited at
295 nm. In contrast, our purified CaM, which does not contain
the amino acid tryptophan (Davis et al., 1986), gave no fluo-
rescent signal in this assay (data not shown). Upon binding of
CaM to the Spc110p-peptides, the environment of the trypto-
2235Spc110p targetting of calmodulinphan in the peptides changed, resulting in a blue-shift in the
emission spectrum maximum from 350 nm to 345 nm (Fig.
5B). This was accompanied by an increase in fluorescence
intensity. The changes of the fluorescence intensity at 330 nm
upon CaM binding to the peptides were used to calculate the
dissociation constant (Kd) of the binding reaction by Scatchard
analysis. Both peptides bound to CaM with high affinity in the
nanomolar range (Fig. 5A). The Kd of the binding reaction was
independent of the Ca2+ concentration for peptide 1. A
moderate twofold increase in Kd (lower affinity) for peptide 2
was measured when Ca2+ was removed by the Ca2+ chelator
EGTA, compared to the affinity in the presence of 39.8 m M
free Ca2+. For both peptides, the Kd of the binding reaction was
unaltered for free Ca2+ concentrations up to 1 mM (data not
shown). The stoichiometry of the binding reactions was close
to one (n=0.9±0.3) indicating that one peptide bound to one
CaM molecule. CaM-binding studies using a synthetic
substrate (KKRELIESKWHRLLFHDKK) of the related
Cdc31p revealed a Kd above 10 m M (A.S., unpublished), sug-
gesting that high affinity binding of CaM is specific for the
Spc110p-peptides.Fig. 5. The binding of CaM to the CaM-binding site of Spc110p.
(A). The amino acid sequences of synthetic peptides 1 and 2 relative to
Spc110p are shown. Peptide 1 carries a L3W and peptide 2 a L10W
and a C15S exchange. Increasing concentrations of CaM (0.1 to 4 m M)
were titrated to peptides 1 and 2 (1 m M). The change in fluorescence
intensity at 330 nm was used to calculated binding curves. The Kd of
the binding reaction was determined by Scatchard analysis (Scatchard,
1949). The Kd was measured in the presence of either 39.8 m M Ca2+ or
1 mM EGTA. The average of three independent experiments is
indicated. (B) Blue shift of the fluorescence emission maximum of
peptide 1 (1 m M) upon CaM binding (4 m M) from 350 nm to 345 nm.
In addition the relative fluorescence intensity increased. Note, since
CaM does not contain the amino acid tryptophan, it does not contribute
to the fluorescence signal. DISCUSSION
Spc110p directs CaM via its CaM-binding site to the
central plaque of the SPB 
The SPB is a complex structure embedded in the nuclear
envelope, with essential functions in chromosome segregation
and nuclear migration during mitosis and meiosis, in nuclear
fusion during karyogamy and in spore wall formation at the
end of meiosis (Byers, 1981; Byers and Goetsch, 1975).
Despite these essential functions during the entire life cycle of
a yeast cell, only a few SPB components have been identified
and localized to substructures (Fig. 6). For example, Cdc31p
and Kar1p have been localized to the half bridge of the SPB
(Spang et al., 1993, 1995), which has important functions in
SPB duplication. Other SPB substructures are fibres connect-
ing the central and inner plaques. These fibres consist of at least
one SPB protein, Spc110p (Kilmartin et al., 1993). 
CaM is a protein with diverse essential functions in yeast
(Ohya and Botstein, 1994). A fraction of CaM is associated
with the SPB (Geiser et al., 1993; Stirling et al., 1994). In
agreement with this localization, some CMD1 mutants cause
defects in SPB functions and nuclear integrity (Ohya and
Botstein, 1994). The defects in SPB duplication may be the
consequence of a reduced interaction of the mutated CaM with
Spc110p, which contains a CaM-binding site at its carboxy-
terminal end (Geiser et al., 1993; Stirling et al., 1994).
Therefore it was important to determine whether CaM is
directed to the SPB via Spc110p. Our results suggest that
Spc110p is the major and probably the only CaM-bindingFig. 6. Schematic diagram showing the localization of CaM and
indicating the direction of Spc110p at the SPB, relative to other
known SPB components. The localization of Cdc31p (Spang et al.,
1993), Kar1p (Spang et al., 1995), Spc98p (Rout and Kilmartin,
1990; Geissler et al., 1996), Tub4p (Spang et al., 1996), Spc42p
(Donaldson and Kilmartin, 1996), CaM and Spc110p (Kilmartin et
al., 1993) are shown. 
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the association of CaM with the central plaque of the SPB is
dependent on the CaM-binding site of Spc110p (Fig. 6).
However, we were unable to show an interaction of CaM with
Spc110p by immunoprecipitation using anti-Spc110p anti-
bodies or a functional protein A-Spc110p hybrid protein (data
not shown). This may be explained by the dissociation of CaM
from Spc110p during the precipitation procedure.
The function of CaM at the SPB is not understood, especially
since deletion of the CaM binding site of Spc110p does not
cause an obvious growth defect (Geiser et al., 1993) or a defect
in SPB structure (this study). In contrast, point mutations in the
CaM-binding site of Spc110p that reduced CaM-binding in
vitro affected viability of cells (Stirling et al., 1994). Therefore,
it was suggested that the carboxy-terminal domain of Spc110p
has an inhibitory function, which is either relieved by deletion
of this domain or by the binding of CaM (Stirling et al., 1994).
Interestingly, while the entire Spc110p does not interact with
CaM in the two-hybrid system the carboxy-terminal domain of
Spc110p does (Geiser et al., 1993; E.S., unpublished). This
may indicate that the CaM-binding site of Spc110p is buried
in the nuclear form of Spc110p but becomes accessible after
binding to other proteins. One possibility is that CaM ensures
the correct assembly of the SPB after Start of the cell cycle
(Byers, 1981), by binding to Spc110p. 
Spc110p spans the inner and central plaques with
the carboxy terminus embedded in the central
plaque
It has been proposed that Spc110p functions as a spacer protein
spanning the inner and central plaques of the SPB. This model
is based on the finding that deletions in the coiled-coil domain
of Spc110p corresponded to changes in distance between the
inner and central plaques of the SPB (Kilmartin et al., 1993). A
logical consequence of such a model is the association of one
end of Spc110p with the central plaque and the other with the
inner plaque of the SPB. This is consistent with our results, indi-
cating that the association of CaM with the central plaque is
dependent on the CaM-binding site of Spc110p. Since the latter
is located near the carboxy terminus of Spc110p, we suggest
that this part of Spc110p is close to the central plaque (Fig. 6).
Confirming the extended nature of Spc110p, antibodies directed
against the amino-terminal 175 amino acids of Spc110p
labelled the inner plaque of the SPB. Taken together, our results
confirm that Spc110p is an extended molecule at the SPB and
in addition, they define the topology of Spc110p with the amino
terminus directed towards the inner plaque and the carboxy
terminus associated with the central plaque of the SPB (Fig. 6). 
In agreement with other reports, we found a fraction of
Spc110p within the nucleus of yeast cells (Kilmartin et al.,
1993). Since our affinity-purified anti-Spc110p antibodies are
highly specific for Spc110p (Spang et al., 1995) and the same
signal was obtained by rabbit and goat anti-N-Spc110p anti-
bodies, we are confident that we detected Spc110p and not a
cross-reactive protein. The nuclear Spc110p may be a
precursor of the SPB associated form. Alternatively, Spc110p
could have additional functions e.g. in organizing the nucleus. 
CaM binds to Spc110p with high affinity but
independent of Ca2+
We measured the binding of CaM to synthetic peptides corre-sponding to the CaM-binding site of Spc110p. The CaM
binding region of Spc110p has been defined by a deletion
analysis (Geiser et al., 1993) as well as by mutations in
Spc110p affecting the in vitro binding of CaM (Stirling et al.,
1994). The minimal region of Spc110p which is required for
the interaction with CaM seems to span amino acids 901-914
(Stirling et al., 1994). The peptides used in our binding study
corresponded to amino acids 897-917 of Spc110p and therefore
included the entire CaM-binding site of Spc110p. For our mea-
surements the amino acid leucine of the Spc110p-peptide was
changed to tryptophan to allow monitoring of the binding of
CaM to the peptides by changes in fluorescence. Similar mod-
ifications have been introduced into the CaM-binding sites of
myosin light chain kinase and affect the affinity of the binding
reaction mostly by factors of 0.7 to 2 (O’Neil et al., 1987).
This, and the fact that we obtained very similar Kd values for
both Spc110p-peptides, suggest that our results reflect the
behaviour of the unmodified peptide. 
To our knowledge, we report the first quantitative binding
studies for yeast calmodulin. The stoichiometry of the reaction
was close to one, indicating that one calmodulin bound to one
Spc110-peptide. The Kd of the binding reaction was in the 100
nM range for both peptides. This is relatively high compared
to the 1 nM to 10 nM Kd values determined for the binding of
target peptides to vertebrate calmodulin (O’Neil et al., 1987).
We do not think that the peptide length of 21 amino acids is
responsible for the lower affinity binding since this is above
what has been used in comparable studies with vertebrate
calmodulin (17 to 20 amino acids; O’Neil et al., 1987).
Whether the lower affinity binding of CaM to target proteins
is a general feature in yeast or a specific property of the CaM-
Spc110p interaction remains to be determined. Since Ca2+ is
not an essential modulator for CaM’s binding activity in yeast
(Geiser et al., 1991), lower affinity binding of CaM may be
required to ensure the dissociation of CaM from target
proteins. 
We found that the Kd of CaM-peptide binding was not influ-
enced (peptide 1) or only slightly influenced (twofold; peptide
2) by Ca2+. Ca2+-independent binding of CaM was expected
on the one hand, since high-affinity Ca2+ binding is evidently
not required for calmodulin’s essential functions (Geiser et al.,
1991). On the other hand the interaction of CaM with filter-
immobilized Spc110p was dependent on Ca2+ (Spang et al.,
1995). These contrary results may be explained by the
denatured state of Spc110p in the filter binding assay. Alter-
natively, amino acids flanking the CaM-binding site of
Spc110p, which are not present in peptides 1 and 2, may
mediate Ca2+-dependent interaction with CaM in vivo. 
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